Zesheng Li

Zesheng Li

Auto-generated profile, based on publicly available information

Zesheng Li

Department of Neurosurgery Xuanwu Hospital, Capital medical University Beijing China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2025 in Neuroscience Bulletin
Verified
Journal Article
Open access
PDF file
JSJianwei Shi
Jianwei Shi
JXJing Xie
Jing Xie
ZLZesheng Li
Zesheng Li
XHXiaosong He
Xiaosong He
PWPenghu Wei
Penghu Wei
GZGuoguang Zhao
Guoguang Zhao
Epilepsy affects over 50 million people worldwide. Drug-resistant epilepsy (DRE) accounts for up to a third of these cases, and neuro-inflammation is thought to play a role in such cases. Despite being a long-debated issue in the field of DRE, the mechanisms underlying neuroinflammation have yet to be fully elucidated. The pro-inflammatory microenvironment within the brain tissue of people with DRE has been probed using single-cell multimodal transcriptomics. Evidence suggests that inflammatory cells and pro-inflammatory cytokines in the nervous system can lead to extensive biochemical changes, such as connexin hemichannel excitability and disruption of neurotransmitter homeostasis. The presence of inflammation may give rise to neuronal network abnormalities that suppress endogenous antiepileptic systems. We focus on the role of neuroinflammation and brain network anomalies in DRE from multiple perspectives to identify critical points for clinical application. We hope to provide an insightful overview to advance the quest for better DRE treatments.

14 October 2025 in Advanced Science
Verified
Journal Article
Open access
JSJianwei Shi
Jianwei Shi
ZLZesheng Li
Zesheng Li
XSXin Sun
Xin Sun
YYYanfeng Yang
Yanfeng Yang
YLYumin Luo
Yumin Luo
GZGuoguang Zhao
Guoguang Zhao
Temporal lobe epilepsy (TLE), the most common form of epilepsy, is primarily characterized by hippocampal sclerosis (HS). Microglia reactivity is a critical component of TLE pathogenesis, and apolipoprotein E (APOE) may be a potential mediator of these processes. However, its role in TLE progression remains unclear. Bioinformatics approaches with biomarker validation are integrated to elucidate APOE's role and hippocampal microglia in the mechanisms underlying TLE. APOE expression is significantly elevated in the hippocampal tissues of patients with TLE‐HS and in TLE mouse models. Single‐cell RNA sequencing reveals a subset of microglia with high APOE gene expression, which serves as the principal carrier of increased APOE during disease progression. Bioinformatic analyses, in vitro studies, and in vivo functional experiments utilizing TLE mouse models implicate these APOE ‐expressing microglia in regulating microglial differentiation, promoting neuroinflammation, neuronal apoptosis, and enhancing neuronal excitability. Genetic knockout of APOE mitigates gliosis, neuronal cell death, and seizure frequency in the hippocampus of epileptic mice. Additionally, APOE expression primarily induces significant alterations in glycerophospholipid metabolism and its associated metabolic derivatives within the epileptic microenvironment. Overall, APOE ‐expressing microglia are pivotal drivers of HS and TLE progression, positioning APOE and its downstream signaling pathways as promising therapeutic TLE targets.

30 June 2026 in Epilepsia
Verified
Journal Article
Open access
PDF file
ZYZiqian Yan
Ziqian Yan
TTTing Tang
Ting Tang
KWKaishan Wang
Kaishan Wang
BFBin Fu
Bin Fu
ZLZesheng Li
Zesheng Li
GZGuoguang Zhao
Guoguang Zhao
Objective: This study aimed to investigate the regulatory roles of distinct neuronal subtypes within the anterior cingulate cortex (ACC) in acute seizures and to identify cell type‐specific mechanisms underlying seizure modulation in this region. Methods: Acute seizure models were established in mice via pentylenetetrazol injection. In vivo fiber photometry and miniscope calcium imaging were employed to monitor neuronal calcium activity, and multichannel electroencephalography was used to record brain electrical signals simultaneously. Subsequently, bidirectional chemogenetic and optogenetic manipulations were performed on calcium/calmodulin‐dependent protein kinase II (CaMKII) excitatory neurons and vesicular γ‐aminobutyric acid (GABA) transporter (vGAT)‐expressing GABAergic interneurons, as well as parvalbumin (PV) and somatostatin (SST) interneuron subpopulations. Results: Calcium recordings demonstrated that both excitatory and inhibitory neurons in the ACC exhibited significant, temporally coordinated hyperactivity during acute seizures. Inhibition of CaMKII neurons significantly reduced seizure severity, whereas their activation induced spontaneous seizurelike activity. Enhancing GABAergic interneuron activity significantly decreased seizure frequency and severity. Notably, inhibition of GABAergic interneurons resulted in markedly more severe seizures. Further examination of interneuron subtypes revealed functional heterogeneity; activation of SST interneurons effectively suppressed seizures, whereas PV activation did not produce significant antiseizure effects. Critically, inhibition of either PV or SST interneurons triggered spontaneous seizurelike activity, indicating that both subtypes are necessary for maintaining network stability. Significance: This study elucidates the differential roles of ACC neuronal populations in acute seizure dynamics. Activating GABAergic interneurons or inhibiting CaMKII‐positive neurons effectively suppresses seizure activity. Among interneuron subtypes, SST activation reduces seizures, whereas PV activation does not. However, inhibiting either subtype triggers spontaneous epileptiform activity, indicating both are indispensable and play complementary roles in maintaining network homeostasis. These findings reveal the microcircuit mechanisms by which the ACC modulates acute seizures, highlighting that cortical stability relies on both the classical excitation–inhibition balance and the cooperative interplay of multiple interneuron subtypes.

5 October 2026 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
PDF file
ZLZesheng Li
Zesheng Li
QWQian Wu
Qian Wu
YYYanfeng Yang
Yanfeng Yang
JSJianwei Shi
Jianwei Shi
XNXuegang Niu
Xuegang Niu
GZGuoguang Zhao
Guoguang Zhao
Aims: Epilepsy is a common neurological disorder, often presenting with psychiatric comorbidities and cognitive impairment. Neuroimaging studies have suggested associations between epilepsy and subcortical volumetric abnormalities. The genetic basis between epilepsy and subcortical volume abnormalities is, however, poorly understood, particularly if they share a common genetic architecture. Methods: To investigate polygenic overlap, we employed the bivariate causal mixture model (MiXeR) to analyze genome‐wide association data from various epilepsy subtypes (genetic generalized epilepsy [GGE]: n = 49,388, all epilepsy [EP]: n = 69,995, focal epilepsy: n = 57,375) and 16 subcortical volumetric phenotypes ( n = 33,224). We identified shared genomic loci through conditional and conjunctional false discovery rate analyses (cond/conjFDR). Results: MiXeR results suggest substantial shared genetic variants between subcortical volume and common epilepsies. ConjFDR analysis identified 33 distinct shared loci between GGE and subcortical volumetric phenotypes. The shared loci were mapped to 322 protein‐coding genes. Among these, 49 genes showed significant expression‐trait associations with both GGE and subcortical volume phenotypes, and 12 of the 322 genes were also associated with cognitive, mental health, and personality‐related traits. Conclusion: We dissected the shared genetic architecture between common epilepsies and subcortical volumes. Expression‐trait association analyses further identified candidate genes associated with cognitive, mental health, and personality‐related phenotypes.

23 September 2026 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
PDF file
ZLZesheng Li
Zesheng Li
YWYihe Wang
Yihe Wang
JSJianwei Shi
Jianwei Shi
YLYumin Luo
Yumin Luo
YSYongzhi Shan
Yongzhi Shan
GZGuoguang Zhao
Guoguang Zhao
Background: Focal cortical dysplasia Type II (FCD II) is a major cause of drug‐resistant epilepsy in children. Somatic mosaic variants affecting the PI3K–AKT–mTOR pathway are implicated in a substantial proportion of cases. The links between genotype, cellular pathology, epileptogenic networks, and clinical outcome remain incompletely defined. Methods: This review synthesizes evidence on somatic mTOR–pathway variants, lesion development, pathological cell populations, circuit mechanisms, single‐cell and spatial multi‐omics approaches in FCD II. Results: The developmental timing, lineage distribution, and local expansion of somatic variants influence lesion extent and phenotypic heterogeneity. Dysmorphic neurons may contribute to epileptogenicity through altered intrinsic excitability and synaptic function, whereas balloon cells may predominantly affect local circuits through secretory and microenvironmental mechanisms. mTOR hyperactivation may also alter interneuron development, subtype specification, and synaptic connectivity, thereby disrupting excitation‐inhibition balance. Single‐cell and spatial approaches, including RNA velocity, pseudotime analysis, chromatin‐age inference, and somatic genotyping, provide tools to resolve pathological cell states and lineage trajectories. Conclusions: FCD II should be considered a mosaic developmental disorder involving both cell‐autonomous and non‐cell‐autonomous mechanisms. Integrating somatic variant detection with cellular, spatial, electrophysiological, and surgical outcomes from matched patient tissue may enable biologically meaningful stratification and support the development of novel therapies.